<?xml version="1.0"?>
<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.4 20190208//EN"
       "JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.4" xml:lang="en">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">Scientific Notes of V.I. Vernadsky Crimean Federal University. Biology. Chemistry</journal-id>
   <journal-title-group>
    <journal-title xml:lang="en">Scientific Notes of V.I. Vernadsky Crimean Federal University. Biology. Chemistry</journal-title>
    <trans-title-group xml:lang="ru">
     <trans-title>Ученые записки Крымского федерального университета имени В.И. Вернадского. Биология. Химия.</trans-title>
    </trans-title-group>
   </journal-title-group>
   <issn publication-format="print">2413-1725</issn>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="publisher-id">100807</article-id>
   <article-id pub-id-type="doi">10.29039/2413-1725-2025-11-1-310-320</article-id>
   <article-categories>
    <subj-group subj-group-type="toc-heading" xml:lang="ru">
     <subject>ХИМИЧЕСКИЕ НАУКИ</subject>
    </subj-group>
    <subj-group subj-group-type="toc-heading" xml:lang="en">
     <subject>CHEMICAL SCIENCES</subject>
    </subj-group>
    <subj-group>
     <subject>ХИМИЧЕСКИЕ НАУКИ</subject>
    </subj-group>
   </article-categories>
   <title-group>
    <article-title xml:lang="en">SYNTHESIS AND PREDICTED ANTI-TUBERCULOSIS ACTIVITY OF DERIVATIVES OF (2-METHYL-1H-BENZIMIDAZOLE-1-YL)ETHANOIC AND (5,6-DIMETHYL-1H-BENZIMIDAZOLE-1-YL)ETHANOIC ACIDS</article-title>
    <trans-title-group xml:lang="ru">
     <trans-title>СИНТЕЗ И ПРОГНОЗИРУЕМАЯ ПРОТИВОТУБЕРКУЛЁЗНАЯ АКТИВНОСТЬ ПРОИЗВОДНЫХ (2-МЕТИЛ-1H-БЕНЗИМИДАЗОЛ-1-ИЛ)ЭТАНОВОЙ И (5,6-ДИМЕТИЛ-1H-БЕНЗИМИДАЗОЛ-1-ИЛ)ЭТАНОВОЙ КИСЛОТ</trans-title>
    </trans-title-group>
   </title-group>
   <contrib-group content-type="authors">
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Сарнит</surname>
       <given-names>Е. А.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Sarnit</surname>
       <given-names>E. A.</given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-1"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Цикалов</surname>
       <given-names>В. В.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Cikalov</surname>
       <given-names>V. V.</given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-1"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Поддубов</surname>
       <given-names>А. И.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Poddubov</surname>
       <given-names>A. I.</given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-1"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Перошкова</surname>
       <given-names>Д. А.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Peroshkova</surname>
       <given-names>D. A.</given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-1"/>
    </contrib>
   </contrib-group>
   <aff-alternatives id="aff-1">
    <aff>
     <institution xml:lang="ru">Крымский федеральный университет имени В.И.Вернадского</institution>
    </aff>
    <aff>
     <institution xml:lang="en">Crimean Federal University of a name of V.I.Vernadsky</institution>
    </aff>
   </aff-alternatives>
   <pub-date publication-format="print" date-type="pub" iso-8601-date="2025-07-01T13:06:14+03:00">
    <day>01</day>
    <month>07</month>
    <year>2025</year>
   </pub-date>
   <pub-date publication-format="electronic" date-type="pub" iso-8601-date="2025-07-01T13:06:14+03:00">
    <day>01</day>
    <month>07</month>
    <year>2025</year>
   </pub-date>
   <volume>11</volume>
   <issue>1</issue>
   <fpage>310</fpage>
   <lpage>320</lpage>
   <history>
    <date date-type="received" iso-8601-date="2025-07-01T00:00:00+03:00">
     <day>01</day>
     <month>07</month>
     <year>2025</year>
    </date>
   </history>
   <self-uri xlink:href="https://sn-biolchem.cfuv.ru/&#x441;&#x438;&#x43D;&#x442;&#x435;&#x437;-&#x438;-&#x43F;&#x440;&#x43E;&#x433;&#x43D;&#x43E;&#x437;&#x438;&#x440;&#x443;&#x435;&#x43C;&#x430;&#x44F;-&#x43F;&#x440;&#x43E;&#x442;&#x438;&#x432;&#x43E;&#x442;&#x443;&#x431;&#x435;/">https://sn-biolchem.cfuv.ru/синтез-и-прогнозируемая-противотубе/</self-uri>
   <abstract xml:lang="ru">
    <p>Приведены методики синтезов гидразидов, салицилиденгидразонов и 1,2,4-триазолов – производных&#13;
(2-метил-1H-бензимидазол-1-ил)этановой и (5,6-диметил-1H-бензимидазол-1-ил)этановой кислот. Показано, что стандартные методики синтеза гидразидов, ацилгидразонов и 1,2,4-триазолов, используемые для синтеза аналогичных производных алифатических кислот, применимы и к соединениям, содержащим в своём составе фрагмент бензимидазола. Состав и структуры исходных и синтезированных соединений подтверждены данными элементного анализа, ПМР- и ИК-спектроскопии. Прогноз потенциальной биологической активности синтезированных соединений по структурной формуле был осуществлен с использованием веб-ресурса PASSOnline. Проведен сравнительный анализ прогнозируемой биологической активности. При сопоставлении полученных данных по гидразидам, салицилиденгидразонам и 1,2,4-триазолам, соответственно, показано, что при переходе от гидразида&#13;
(2-метил-1H-бензимидазол-1-ил)этановой кислоты к гидразиду (5,6-диметил-1H-бензимидазол-1-ил)этановой кислоты наблюдается незначительное увеличение прогнозируемой противотуберкулёзной активности, тогда как у соответствующих салицилиденгидразонов наблюдается обратная зависимость. 1,2,4-Триазолы практически не проявляют данный вид биологической активности.</p>
   </abstract>
   <trans-abstract xml:lang="en">
    <p>In this work, hydrazides, salicylidenehydrazones and 1,2,4-triazoles (2-methyl-1H-benzimidazol-1-yl)ethanoic and (5,6-dimethyl-1H-benzimidazol-1-yl)ethanoic acids were synthesized and studied. It was shown that standard methods for the synthesis of hydrazides, acylhydrazones and triazoles are also applicable to benzimidazole derivatives. The conversion of hydrazides to salicylidene hydrazones and 1,2,4-triazoles leads to an increase in the stability of the compounds, since. Storing hydrazides of these acids in air leads to their slow oxidation. A prediction was made of the potential biological activity of the synthesized hydrazides, salicylidenehydrazones and 1,2,4-triazoles using the PASSOnline Internet service. In the series of compounds hydrazide – salicylidehydrazone and 1,2,4-triazole for (2-methyl-1H-benzimidazol-1-yl)ethanoic acid the calculated Pa value was 0.625 – 0.757 – 0.258, respectively. For (5,6-dimethyl-1H-benzimidazol-1-yl)ethanoic acid the calculated Pa value was 0.641 – 0.405, respectively. 1,2,4-Triazole does not have this activity. Using the PASSOnline program, it was shown that when moving from (2-methyl-1H-benzimidazol-1-yl)ethanoic acid hydrazide to (5,6-dimethyl-1H-benzimidazol-1-yl)ethanoic acid hydrazide, a slight increase in anti-tuberculosis activity is observed (Pa = 0.625 and 0.641). For the corresponding salicylidene hydrazones, an inverse dependence of this type of activity was observed. 1,2,4-Triazoles practically do not exhibit this type of biological activity, which is due to the blocking of the active hydrazide group. The composition and structures of the starting and synthesized compounds were confirmed by elemental analysis, PMR and IR spectroscopy.</p>
   </trans-abstract>
   <kwd-group xml:lang="ru">
    <kwd>бензимидазол</kwd>
    <kwd>гидразид</kwd>
    <kwd>ацилгидразон</kwd>
    <kwd>салицилиденгидразон</kwd>
    <kwd>1</kwd>
    <kwd>2</kwd>
    <kwd>4-триазол</kwd>
    <kwd>биологическая активность</kwd>
    <kwd>противотуберкулёзная активность</kwd>
    <kwd>PASSOnline</kwd>
   </kwd-group>
   <kwd-group xml:lang="en">
    <kwd>benzimidazole</kwd>
    <kwd>hydrazide</kwd>
    <kwd>acylhydrazone</kwd>
    <kwd>salicylidenehydrazone</kwd>
    <kwd>1</kwd>
    <kwd>2</kwd>
    <kwd>4-triazole</kwd>
    <kwd>biological activity</kwd>
    <kwd>anti-tuberculosis activity</kwd>
    <kwd>PASSOnline</kwd>
   </kwd-group>
  </article-meta>
 </front>
 <body>
  <p></p>
 </body>
 <back>
  <ref-list>
   <ref id="B1">
    <label>1.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Shah K. Benzimidazole: a promising pharmacophore / K. Shah, S. Chhabra, S. K. Shrivastava, P. Mishra // Med. Chem. Res. – 2013. – Vol. 22, № 11. – P. 5077–5104.</mixed-citation>
     <mixed-citation xml:lang="en">Shah K. Benzimidazole: a promising pharmacophore / K. Shah, S. Chhabra, S. K. Shrivastava, P. Mishra // Med. Chem. Res. – 2013. – Vol. 22, № 11. – P. 5077–5104.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B2">
    <label>2.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Ajani  O.  O.  Functionalized  Benzimidazole  Scaffolds:  Privileged  Heterocycle  for  Drug  Design  in Therapeutic Medicine / O. O. Ajani, D. V.Aderohunmu, C. O. Ikpo, A. E. Adedapo, I. O.Olanrewaju // Arch. Pharm.</mixed-citation>
     <mixed-citation xml:lang="en">Ajani  O.  O.  Functionalized  Benzimidazole  Scaffolds:  Privileged  Heterocycle  for  Drug  Design  in Therapeutic Medicine / O. O. Ajani, D. V.Aderohunmu, C. O. Ikpo, A. E. Adedapo, I. O.Olanrewaju // Arch. Pharm.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B3">
    <label>3.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Рубцов М. В. Синтетические химико-фармацевтические препараты / М. В. Рубцов, А. Г. Байчиков. – М.: Медицина, 1971. – 328 с.</mixed-citation>
     <mixed-citation xml:lang="en">Rubcov M. V. Sinteticheskie himiko-farmacevticheskie preparaty / M. V. Rubcov, A. G. Baychikov. – M.: Medicina, 1971. – 328 s.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B4">
    <label>4.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Машковский  Д.  М.  Лекарственные  средства.  Изд.  16.  /  Д.  М.  Машковский.  –  М.:  Новая  волна, 2020. – 1216 c.</mixed-citation>
     <mixed-citation xml:lang="en">Mashkovskiy  D.  M.  Lekarstvennye  sredstva.  Izd.  16.  /  D.  M.  Mashkovskiy.  –  M.:  Novaya  volna, 2020. – 1216 c.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B5">
    <label>5.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Vekariya N. A. Synthesis of isoxazoles and quinoxalines as potential anticancer agents / N. A. Vekariya // Indian Journal of Chemistry. – 2003. – Vol. 42B. – Р. 421–424.</mixed-citation>
     <mixed-citation xml:lang="en">Vekariya N. A. Synthesis of isoxazoles and quinoxalines as potential anticancer agents / N. A. Vekariya // Indian Journal of Chemistry. – 2003. – Vol. 42B. – R. 421–424.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B6">
    <label>6.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Soni  L.  K.  Anti-microbial  benzimidazole  derivatives:  synthesis  and  in  vitro  biological  evaluation  / L. K. Soni, T. Narsinghani, A. Sethi // Med. Chem. Res. – 2012. – Vol. 21. – № 12. – P. 4330–4334.</mixed-citation>
     <mixed-citation xml:lang="en">Soni  L.  K.  Anti-microbial  benzimidazole  derivatives:  synthesis  and  in  vitro  biological  evaluation  / L. K. Soni, T. Narsinghani, A. Sethi // Med. Chem. Res. – 2012. – Vol. 21. – № 12. – P. 4330–4334.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B7">
    <label>7.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Спасов  А.  А.  Антисеротониновая  активность  производных  трициклических  бензимидазольных систем / А. А. Спасов, М. В. Черников, Д. С.Яковлев//Хим.-фармац. журнал.– 2006.–Т. 40, № 11.– С.23–26.</mixed-citation>
     <mixed-citation xml:lang="en">Spasov  A.  A.  Antiserotoninovaya  aktivnost'  proizvodnyh  triciklicheskih  benzimidazol'nyh sistem / A. A. Spasov, M. V. Chernikov, D. S.Yakovlev//Him.-farmac. zhurnal.– 2006.–T. 40, № 11.– S.23–26.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B8">
    <label>8.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Пожарский А. Ф. Синтез N-алкилбензимидазолов / А. Ф. Пожарский, А. М. Симонов // Журн. орг. хим. – 1963. – Т. 33. – С. 179–181.</mixed-citation>
     <mixed-citation xml:lang="en">Pozharskiy A. F. Sintez N-alkilbenzimidazolov / A. F. Pozharskiy, A. M. Simonov // Zhurn. org. him. – 1963. – T. 33. – S. 179–181.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B9">
    <label>9.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Soundararajan  R.  Regioselective  N-alkylation  of  benzimidazole  via  an  organotin  route  / R. Soundararajan, T. Balasubramanian // Tetrahedron Lett. – 1984. – Vol. 25, № 48. – P. 5555–5558.</mixed-citation>
     <mixed-citation xml:lang="en">Soundararajan  R.  Regioselective  N-alkylation  of  benzimidazole  via  an  organotin  route  / R. Soundararajan, T. Balasubramanian // Tetrahedron Lett. – 1984. – Vol. 25, № 48. – P. 5555–5558.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B10">
    <label>10.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Щукина  М.  Н.  Ароматические  изоникотиноилгидразоны  –  новый  класс  химиотерапевтических противотуберкулезных веществ / М. Н. Щукина, Г. Н. Першин, Е. Д. Сазонова, О. О. Макеева // Проблемы</mixed-citation>
     <mixed-citation xml:lang="en">Schukina  M.  N.  Aromaticheskie  izonikotinoilgidrazony  –  novyy  klass  himioterapevticheskih protivotuberkuleznyh veschestv / M. N. Schukina, G. N. Pershin, E. D. Sazonova, O. O. Makeeva // Problemy</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B11">
    <label>11.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Поройков В. В. Компьютерный прогноз биологической активности химических соединений как основа  для  поиска  и  оптимизации  базовых  структур  новых  лекарств  /  В.  В.  Поройков, Д. А. Филимонов</mixed-citation>
     <mixed-citation xml:lang="en">Poroykov V. V. Komp'yuternyy prognoz biologicheskoy aktivnosti himicheskih soedineniy kak osnova  dlya  poiska  i  optimizacii  bazovyh  struktur  novyh  lekarstv  /  V.  V.  Poroykov, D. A. Filimonov</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B12">
    <label>12.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Pharma  expert  predictive  services  «PASSОnline»  [Electronic  resource]:  FSBI  «Research  Institute  of biomedical  chemistry  named  after  V.  N.  Orekhovich»  The  Russian  Academy  of  medical  Sciences.  –</mixed-citation>
     <mixed-citation xml:lang="en">Pharma  expert  predictive  services  «PASSOnline»  [Electronic  resource]:  FSBI  «Research  Institute  of biomedical  chemistry  named  after  V.  N.  Orekhovich»  The  Russian  Academy  of  medical  Sciences.  –</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B13">
    <label>13.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Иоффе  Б.  В.  Химия  органических  производных  гидразина  /  Б.  В.  Иоффе,  М.  А.  Кузнецов, А. А. Потехин. – Л.: Химия, 1979. – 224 с.</mixed-citation>
     <mixed-citation xml:lang="en">Ioffe  B.  V.  Himiya  organicheskih  proizvodnyh  gidrazina  /  B.  V.  Ioffe,  M.  A.  Kuznecov, A. A. Potehin. – L.: Himiya, 1979. – 224 s.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B14">
    <label>14.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Potts K. T. The Chemistry of 1,2,4-Triazoles / K. T. Potts // Chem. Rev. 1961. – Vol. 61. – P. 87–127.</mixed-citation>
     <mixed-citation xml:lang="en">Potts K. T. The Chemistry of 1,2,4-Triazoles / K. T. Potts // Chem. Rev. 1961. – Vol. 61. – P. 87–127.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B15">
    <label>15.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Сильверстейн Р. Спектрометрическая идентификация органических соединений: учеб. пособие / Р. Сильверстейн, Г. Басслер, Т. Морил. – М.: Мир, 1977. – С. 125–215.</mixed-citation>
     <mixed-citation xml:lang="en">Sil'versteyn R. Spektrometricheskaya identifikaciya organicheskih soedineniy: ucheb. posobie / R. Sil'versteyn, G. Bassler, T. Moril. – M.: Mir, 1977. – S. 125–215.</mixed-citation>
    </citation-alternatives>
   </ref>
  </ref-list>
 </back>
</article>
